Potomac advises the Swiss orthopedic manufacturer Mediliant in its implantation in the US through the acquisition of Medical Device & Implants, a specialist in extremity implants

Based in Switzerland, in the heart of a dynamic medical industry, Mediliant, is an orthopedic contract manufacturer created in 2014 through the acquisition of a Zimmer Biomet entity.

Quickly Mediliant established itself with a full-service offer to customers for their implant production from the management of regulatory affairs under multiple standards American, European to design and machining phases up to cleaning and sterile packaging.

With the support of its main shareholder since 2019, Ekkio Capital, Mediliant and its management have the ambition to become a leading orthopedic manufacturer specialized in spine, extremity, and trauma implants.

Financial advisor since the first transaction in 2019, Potomac Transactions advised Mediliant and Ekkio Capital on their first acquisition in the US, Medical Device & Implants (“MDI”) and on the financing of the transaction. Based in Lancaster, Pennsylvania, MDI is a specialist in contract manufacturing extremity implants.

For Mediliant, the US market is a key step to quickly reach its first target of $100 million in revenues.